Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures

被引:0
|
作者
Furusawa, Yuri [1 ,2 ]
Kiso, Maki [3 ]
Uraki, Ryuta [1 ,2 ,3 ]
Sakai-Tagawa, Yuko [2 ]
Nagai, Hiroyuki [4 ]
Koga, Michiko [4 ,5 ]
Kashima, Yukie [6 ]
Hojo, Masayuki [7 ]
Iwamoto, Noriko [8 ]
Iwatsuki-Horimoto, Kiyoko [3 ]
Ohmagari, Norio [8 ]
Suzuki, Yutaka [6 ]
Yotsuyanagi, Hiroshi [4 ,5 ]
Halfmann, Peter J. [9 ]
Kamitani, Wataru [10 ]
Yamayoshi, Seiya [1 ,2 ,3 ,11 ]
Kawaoka, Yoshihiro [1 ,2 ,3 ,9 ]
机构
[1] Natl Ctr Global Hlth & Med Res Inst, Res Ctr Global Viral Dis, Tokyo, Tokyo, Japan
[2] Univ Tokyo, Inst Med Sci, Div Virol, Tokyo, Tokyo, Japan
[3] Univ Tokyo, Pandem Preparedness Infect & Adv Res Ctr, Tokyo, Tokyo, Japan
[4] Univ Tokyo, IMSUT Hosp, Inst Med Sci, Dept Infect Dis & Appl Immunol, Tokyo, Tokyo, Japan
[5] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Infect Dis, Tokyo, Tokyo, Japan
[6] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Tokyo, Tokyo, Japan
[7] Natl Ctr Global Hlth & Med, Dept Resp Dis, Tokyo, Tokyo, Japan
[8] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Tokyo, Japan
[9] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA
[10] Gunma Univ, Grad Sch Med, Dept Infect Dis & Host Def, Gunma, Japan
[11] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Tokyo, Japan
关键词
SARS-CoV-2; COVID-19; coronavirus;
D O I
10.1128/jvi.02217-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In general, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replicates well at 37 degrees C, which is the temperature of the human lower respiratory tract, but it poorly at 30 degrees C-32 degrees C, which is the temperature of the human upper respiratory tract. The replication efficiency of SARS-CoV-2 in the upper respiratory tract may directly affect its transmissibility. In this study, an XBB.1.5 isolate showed superior replicative ability at 32 degrees C and 30 degrees C, whereas most other Omicron sub-variant isolates showed limited growth. Deep sequencing analysis demonstrated that the frequencies of viruses possessing the NSP6-S163P and NSP13-P238S substitutions increased to more than 97% during propagation of the XBB.1.5 isolate at 32 degrees C but did not reach 55% at 37 degrees C. Reverse genetics revealed that these substitutions contributed to superior virus growth in vitro at these low temperatures by improving virus genome replication. Mutant virus possessing both substitutions showed slightly higher virus titers in the upper respiratory tract of hamsters compared to the parental virus; however, transmissibility between hamsters was similar for the mutant and parental viruses. Taken together, our findings indicate that NSP6-S163P and NSP13-P238S contribute to superior virus growth at low temperatures in vitro and in the upper respiratory tract of hamsters. IMPORTANCE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replicates efficiently at 37 degrees C. However, the temperature of the human upper airway is 30 degrees C-32 degrees C. Therefore, the replicative ability of SARS-CoV-2 at low temperatures could influence virus replication in the upper airway and transmissibility. In this study, we assessed the growth of Omicron sub-variants at low temperatures and found that an XBB.1.5 isolate showed increased replicative ability. By deep sequencing analysis and reverse genetics, we found that amino acid changes in NSP6 and NSP13 contribute to the low-temperature growth; these changes improved RNA polymerase activity at low temperatures and enhanced virus replication in the upper airway of hamsters. Although these substitutions alone did not drastically affect virus transmissibility, in combination with other substitutions, they could affect virus replication in humans. Furthermore, since these substitutions enhance virus replication in cultured cells, they could be used to improve the production of inactivated or live attenuated vaccine virus.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity
    Mohammad, Thahani S. Habeeb
    Gupta, Yash
    Reidl, Cory T.
    Nicolaescu, Vlad
    Gula, Haley
    Durvasula, Ravi
    Kempaiah, Prakasha
    Becker, Daniel P.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [32] Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism
    Bills, Cody J.
    Xia, Hongjie
    Chen, John Yun-Chung
    Yeung, Jason
    Kalveram, Birte K.
    Walker, David
    Xie, Xuping
    Shi, Pei-Yong
    EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
  • [33] Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation
    Chen, Da-Yuan
    Chin, Chue Vin
    Kenney, Devin
    Tavares, Alexander H.
    Khan, Nazimuddin
    Conway, Hasahn L.
    Liu, GuanQun
    Choudhary, Manish C.
    Gertje, Hans P.
    O'Connell, Aoife K.
    Adams, Scott
    Kotton, Darrell N.
    Herrmann, Alexandra
    Ensser, Armin
    Connor, John H.
    Bosmann, Markus
    Li, Jonathan Z.
    Gack, Michaela U.
    Baker, Susan C.
    Kirchdoerfer, Robert N.
    Kataria, Yachana
    Crossland, Nicholas A.
    Douam, Florian
    Saeed, Mohsan
    NATURE, 2023, 615 (7950) : 143 - +
  • [34] Antiviral Potential of Antillogorgia americana and elisabethae Natural Products against nsp16-nsp10 Complex, nsp13, and nsp14 Proteins of SARS-CoV-2: An In Silico Investigation
    Pokharkar, Omkar
    Lakshmanan, Hariharan
    Zyryanov, Grigory V.
    Tsurkan, Mikhail V.
    MICROBIOLOGY RESEARCH, 2023, 14 (03) : 993 - 1019
  • [35] In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors
    Gurung, Arun Bahadur
    GENE REPORTS, 2020, 21
  • [36] In silico Screening of Phytoconstituents with Antiviral Activities Against SARS-COV-2 Main Protease, Nsp12 Polymerase, and Nsp13 Helicase Proteins
    James, Jainey Puthenveettil
    Jyothi, Divya
    Priya, Sneh
    LETTERS IN DRUG DESIGN & DISCOVERY, 2021, 18 (08) : 841 - 857
  • [37] SARS-CoV-2 NSP13 interacts with host IRF3, blocking antiviral immune responses
    Feng, Kuan
    Zhang, Hui-Jiao
    Min, Yuan-Qin
    Zhou, Min
    Deng, Fei
    Wang, Hua-Lin
    Li, Pei-Qing
    Ning, Yun-Jia
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (06)
  • [38] Development of a Fluorescent Assay and Imidazole-Containing Inhibitors by Targeting SARS-CoV-2 Nsp13 Helicase
    Zhang, Chuang
    Yu, Junhui
    Deng, Mingzhenlong
    Zhang, Qingqing
    Jin, Fei
    Chen, Lei
    Li, Yan
    He, Bin
    MOLECULES, 2024, 29 (10):
  • [39] NSP6 inhibits the production of ACE2-containing exosomes to promote SARS-CoV-2 infectivity
    Lv, Xi
    Chen, Ran
    Liang, Taizhen
    Peng, Haojie
    Fang, Qiannan
    Xiao, Shiqi
    Liu, Sen
    Hu, Meilin
    Yu, Fei
    Cao, Lixue
    Zhang, Yiwen
    Pan, Ting
    Xi, Zhihui
    Ding, Yao
    Feng, Linyuan
    Zeng, Tao
    Huang, Wenjing
    Zhang, Hui
    Ma, Xiancai
    MBIO, 2024, 15 (03):
  • [40] Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study
    R. P. Vivek-Ananth
    Sankaran Krishnaswamy
    Areejit Samal
    Molecular Diversity, 2022, 26 : 429 - 442